BioNTech slid 6.2% as Novartis' failed cholesterol trial hit biotech sentiment, despite BioNTech having no Lp(a) exposure and cutting 2026 guidance.

Rheinmetall shares finished Friday's session at EUR 993.00, down 2.1%, capping a bruising stretch that has left the German ...

Deutz shares have gained 52% since January, lifted by H1 2026 results, FFG takeover clearance, a capital increase and a ...

CIMIC units land data centre, freeway and terminal work while Hochtief's Autmatec purchase sits with Germany's cartel office; shares fell 2.1% for the week.

Industrial doors now link to centralised access-control platforms via RS-485 or Modbus, cutting tailgating and energy use while demanding careful upkeep.

Needham and BTIG raised ServiceNow price targets as analysts weigh AI contract growth against a narrative that may be outpacing the numbers.

Ocugen's chief executive trimmed his stake in the gene-therapy developer this month, offloading 525,991 shares in a move that lands squarely in the middle of a ...

Siemens Energy is sitting on an order book that most industrial companies can only dream of, yet its share price tells a more ...

Ottawa wants drones — not dozens, not hundreds, but millions of them, and within two years. Prime Minister Mark Carney put it bluntly in Calgary on Wednesday, i ...

Novo Nordisk's buyback signals confidence, but Ziltivekimab failures and stock decline set a tense stage for its September 21 ...

Almonty's Sangdong mine begins tungsten production, boosting a 21-year GTP offtake deal. Analysts see upside, but output ...

Greg Abel vows to hold Japan trading houses for decades; Berkshire's portfolio concentrates as Alphabet becomes third-largest ...